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The inflammatory process is a coordinated response that protects host after infection or trauma, 
involving several molecular reactions. Once the inflammation is closely linked to the process of 
destruction of the temporomandibular joint, this study aims to examine, by immunohistochemistry, 
the expression of interleukin-6 (IL-6), an important inflammatory marker, in temporomandibular 
articular discs of patients with anterior disc displacement with (ADDwR) and without reduction 
(ADDwoR) and its association with osteoarthrosis (OA). Thirty-eight (n = 38) articular discs were divided 
into two cutoffs: 1) analysis 1: 4 control (acute pathology), 17 ADDwR, 17 ADDwoR; and 2) analysis 2: 
without OA (n = 21) and with OA (n = 17). The area of immunostaining was compared statistically 
between groups (p < 0.05). In the disc samples, no significant differences were observed between the 
groups ADDwR and ADDwoR, and with and without OA, in respect to the expression of IL-6 by 
immunohistochemical examination. Future studies should be conducted with a larger sample size, 
which could clarify the association of the inflammatory mediator IL-6 with temporomandibular joint 
dysfunction. 
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1. Introduction 
A disc derangement is defined as a malposition of the articular disc relative to the condyle and the 
articular eminence of temporal bone and is usually associated with a reduction or loss of disc mobility. 
The most common position associated with internal derangement of the temporomandibular joint is 
anterior disc displacement (pure anterior displacement, anterolateral or anteromedial displacement), 
and it can be divided into with (ADDwR) or without (ADDwoR) reduction (Chiba et al., 2007, 
Huddleston Slater et al., 2005, Westesson et al., 1998). 
In ADDwR, the articular disc of temporomandibular joint (TMJ) is displaced while the mouth is closed 
and the teeth are in contact in maximal occlusion and slide into its functional position as the jaw opens 
(Perez del Palomar and Doblare, 2007, Okeson, 1993). In ADDwoR, the condyle is unable to slide or 
snap back underneath the disc. The displaced disc thus does not reduce to its position on top of the 
condyle during the opening movement (Perez del Palomar and Doblare, 2007, Okeson, 1993). 
Disc displacement results in stretching and inflammation of the retrodiscal tissue, which often results 
in internal derangement (ID) of the TMJ, and it is considered to be a risk factor for osteoarthrosis (OA) 
development, with abnormal remodeling of the condyle and mandibular fossa (Segu et al., 2011, 
Milam et al., 1998, De Bont and Stengenga, 1993, Isacsson et al., 1986). 
ID is characterized by mechanical interference within the joint, associated with progressive disc 
displacement secondary to inflammation, trauma (most common etiologic factor) or degeneration, 
although the real pathogenesis is unclear, and may be associated with genetic predisposition, 
hormonal influence or microbial invasion (Mcintosh and Dimitroulis, 2012, Dimitroulis, 2011, 
Dimitroulis, 2011a). 
Previous studies have shown the correlation between inflammatory processes and destruction of TMJ 
components, and interleukin-6 (IL-6) has been pointed out as one of the most important pro-
inflammatory cytokines contributing to the pathogenesis of TMJ ID (Gunson et al., 2012, Sato et al., 
2003, Nishimura et al., 2002, Kubota et al., 1998, Fu et al., 1995). 
IL-6 is a pleiotropic cytokine produced by several cell types, such as synovial cells, monocytes, 
macrophages, and fibroblasts, in the TMJ (Nishimoto et al., 2000). It regulates immunological reactions, 
inflammation, hematopoiesis and oncogenesis (Gunson et al., 2012, Sato et al., 2003), and it mediates 
the induction of osteoclast progenitor differentiation and osteoclast activity (Fu et al., 1995). 
IL-6 is important to the transition from acute to chronic inflammation (Kaplanski et al., 2003), and 
presents a dual effect; at some levels it acts as pro-inflammatory, whereas in others it can exhibit an 
anti-inflammatory profile (Yamamoto et al., 2000, Alonzi et al., 1998). 
Our objective was to use IL-6 with proven correlation between the process and destruction of TMJ 
components, which has not been studied in articular discs. In this study, we tested the hypothesis that 
this inflammatory marker may be involved in the progression of TMJ ID, as shown by previous 
research, such as that performed by Sato et al. (2003) using immunohistochemistry, in which where 
they found expression of IL-6 in synovial lining cells and in the mononuclear cells infiltrating the 
periphery of the blood vessels. Therefore, the present investigation was designed to evaluate, through 
immunohistochemistry, the expression of IL-6 in TMJ articular discs in ADDwR and ADDwoR patients. 
Moreover, the presence of TMJ OA was also investigated to better understand the relationship 
between TMJ disc displacement and IL-6 expression. 
2. Materials and methods 
2.1. Sample selection 
A convenience sample of 38 temporomandibular discs from 25 patients, mean age 37.9 years (range 
18–56 years), was recruited for study from the patient pool at the Evangelico School Hospital, Curitiba, 
southern region of Brazil (Table 1), as approved by the Ethical Committee on Research at Pontifical 
Catholic University of Paraná, according to Resolution 196/96 of the National Health Council and 
approved under registration number 104. Subjects were not included if they presented with any of the 
following: use of orthodontic appliances; chronic use of anti-inflammatory drugs; history of diabetes, 
hepatitis, HIV infection, or immunosuppressive chemotherapy; history of any disease known to 
severely compromise immune function; current pregnancy or lactation; dentofacial deformity; major 
jaw trauma; previous open TMJ surgery; and previous steroid injection in the TMJ. 
 
  
Table 1. Baseline clinical characteristics of the study group with and without TMJ dysfunction, 
associated with Wilkes stage. 




1 Caucasian F 39 ADDwoR X  V 
2 Caucasian M 27 CFx X   
3 Caucasian F 25 ADDwoR  X V 
4 Caucasian F 46 ADDwoR  X V 
4 Caucasian F 46 ADDwoR X  V 
5 Caucasian F 20 ADDwoR  X V 
5 Caucasian F 20 ADDwoR X  V 
6 Caucasian F 41 ADDwR  X III 
6 Caucasian F 41 ADDwR X  III 
7 Caucasian F 32 ADDwR  X III 
7 Caucasian F 32 ADDwR X  III 
8 Caucasian F 41 ADDwoR  X V 
8 Caucasian F 41 ADDwoR X  V 
9 Caucasian F 26 ADDwR  X III 
9 Caucasian F 26 ADDwR X  III 
10 Caucasian F 28 ADDwR  X III 
10 Caucasian F 28 ADDwR X  III 
11 Caucasian F 36 ADDwR  X III 
11 Caucasian F 36 ADDwR X  III 
12 Caucasian F 18 ADDwR  X III 
12 Caucasian F 18 ADDwR X  III 
13 Caucasian F 38 ADDwoR  X IV 
13 Caucasian F 38 ADDwoR X  IV 
14 Caucasian F 45 ADDwoR X  IV 
15 Caucasian F 51 ADDwoR  X V 
16 Caucasian F 33 ADDwoR X  V 
16 Caucasian F 33 ADDwoR  X V 
17 Caucasian M 22 CFx X   
18 Caucasian F 35 ADDwoR X  IV 
19 Caucasian F 22 ADDwR X  III 
19 Caucasian F 22 ADDwR  X III 
20 Caucasian F 24 ADDwR  X III 
21 Caucasian M 18 CFx X   
22 Caucasian M 37 CFx X   




23 Caucasian F 23 ADDwoR X  IV 
23 Caucasian F 23 ADDwoR  X IV 
24 Caucasian F 42 ADDwR X  III 
25 Caucasian F 56 ADDwR X  III 
ADDWOR, anterior disc displacement without reduction; ADDWR, anterior disc displacement with reduction; CH, 
condylar hyperplasia; CFx, condylar fracture; OA, osteoarthrosis. 
Subjects completed personal medical history questionnaires and, within a protocol approved by an 
institutional review board, signed a consent form after being advised of the nature of the study. All 
patients were asked to complete a pain questionnaire, and a clinical examination was performed 
according to Clinical Practice Guidelines for TMJ surgery of the American Association of Oral 
Maxillofacial Surgeons. Basically, the clinical examination consisted of palpation of the TMJ region, the 
occurrence of painful opening/closing mouth, and crepitation. The patients were considered to be 
affected and treated surgically when presenting painful clinical signs of disc displacement and/or open 
mouth severe limitation after unsuccessful noninvasive treatment for at least 6 months (also including 
arthrocentesis in all patients with anterior disc displacement without reduction; n = 11; 17 specimens). 
Patients presenting with disc displacement with and without reduction were grouped together for 
analysis. Patients with acute pathology were used as controls: 4 individuals presented with extra-
articular condyle fracture (Cfx) with 90° displacement and rupture of the internal structures, confirmed 
by radiographs and CT scan, who needed to be operated on for the fracture reduction and disc 
reposition, as follows: 
1) Subjects without any signs of disc displacement (acute pathology group; n = 4; 4 specimens); 
treated by disc repositioning using a Mitek-anchor. 
2) Patients presenting anterior disc displacement with reduction (ADDwR; n = 10; 17 
specimens); treated by disc repositioning using a Mitek-anchor (15 specimens) or discectomy 
(2 specimens). 
3) Patients presenting with anterior disc displacement without reduction (ADDwoR; n = 11; 17 
specimens); treated by discectomy. 
Subjects were included first in clinical categories according to the presence or absence of disc 
displacement, and second according to the presence or absence of osteoarthrosis using the Wilkes 
classification (Wilkes, 1978). 
Patient selection for OA analysis was based on the primary diagnosis of severe TMJ ID. The stages of 
TMJ ID were classified into mild, intermediate and severe according to Wilkes classification based on 
clinical, surgical, and pathological stages (Wilkes, 1978). Mild ID (Wilkes stage III) is characterized by 
simple disc displacement without any morphological alteration of the disc. The intermediate stage 
(Wilkes stage IV) is characterized by disc displacement and morphological deformity and/or osseous 
remodeling changes. Severe derangement (Wilkes stage V) is characterized by perforations of the disc 
attachments and osseous shift and/or osteoarthritic changes (sclerosis, osteophyte formation, articular 
surface flattening, depression and/or cystic alterations) (Wilkes, 1978). Patients from the control group 
and those classified as Wilkes III were considered as not presenting with OA, and patients classified as 
Wilkes IV or V were included in the OA group, as follows: 
1) Patients without OA (acute pathology group + Wilkes stage III; n = 14; 21 specimens); 
2) Patient with OA (Wilkes stage IV and V; n = 11; 17 specimens). 
Table 1 shows the baseline characteristics of the sample. 
2.2. Surgical technique 
TMJ surgery was performed according to the technique described by Mehra and Wolford, (2001). 
First, the displaced disk is freed by the surgeon entering the upper and lower joint spaces and lysing 
adhesions. At this point, a small hole is placed through the lateral pole of the condyle from the 
posterior to the anterior direction. The Mitek bone-cleat introducer is inserted and pushed into the 
bone, where two small coils unlock and attach the cleat to the inner surface of the condyle cortical 
bone. A nonresorbable 2-0 or 3-0 suture is placed through the hole and through the disk at the 
junction of the posterior and intermediate bands, and the disk is tied down to the condylar neck. The 
deformity of the disk precludes repositioning it into a more normal position, and recontouring the 
thickened disk with a scalpel is necessary (this scalpeled material constitutes the sample). 
This procedure was conducted for all patients with ADDwR (except in two cases) and in the acute 
pathology group, but in all patients with ADDwoR, where there is major commitment of the TMJ disc, 
discectomy was performed according to Miloro and Henriksen (2010). 
In the CFx patients, the disc displaced by fracture was repositioned. Postsurgical physical therapy was 
indicated at the discretion of the surgeon. 
Histological sections obtained by scalpel of disk excess were prepared for observation of the in situ 
expression of IL-6 by immunohistochemistry. 
2.3. Immunohistochemistry 
The TMJ disc sections were deparaffinized with xylol (2 × 10 min) and rehydrated with absolute ethyl 
alcohol (3 × 1 min) and 80% ethyl alcohol (1 × 1 min). Endogenous peroxidase activity was quenched by 
treatment with H2O2 (5% in methanol) for 10 min. Target Retrieval Solution™ (Dako, DK-2600 Glostrup, 
Denmark) was used prior to slide staining for heat-inducing epitope retrieval (for formalin-fixed, 
paraffin-embedded material), according to the manufacturer's instructions. The sections were 
incubated with monoclonal IL-6 antibody (Imuny Biotechnology, Campinas, Brazil), diluted 1:50 in 
phosphate-buffered saline solution (PBS) and 0.1% bovine serum albumin (BSA). For negative controls, 
the primary antibody was not added, and PBS was used instead. The secondary antibody, AdvanceTM 
(Dako, DK-2600 Glostrup, Denmark), was applied for 30 min, according to the manufacturer's 
instructions. 
The immunoreactions were visualized by incubating the sections using 3,3′ diaminobenzidine (DAB) 
chromogen (OriGene, Rockville, MD) (1 drop in 1 mL distilled water). The sections were lightly 
counterstained with Harris hematoxylin for 5 min and finally mounted. Immunostaining was 
considered to be specific to IL-6 because immunoreactivity was not observed in the negative controls. 
The color morphometry method was used to analyze the anti-IL-6 immunostained area in the TMJ disc 
tissue. For this purpose, images of consecutive fields were captured by the 409 objective lens coupled 
with the BX50 Olympus microscope with the Sony camera Model DXC-107A, and image analysis was 
performed with Image Pro Plus software (Media Cybernetics Inc., Silver Spring, MD, USA). This 
software allows an observer to select and paint the positive areas to obtain an image model and make 
the mask for the other stained slides, with an automatic calculation of the area of the positive reaction 
(Fig. 1). This procedure was performed by a single examiner in a blinded manner. The data were 
entered into a spreadsheet, and Microsoft Excel (Microsoft Corporation, Redmond, WA, USA) was used 
for the statistical analysis. The variable area was measured in square micrometers (μm2) and was 
obtained with the mean of all positive areas. 
 
Fig. 1. (A) Photomicrograph showing the positive immunohistochemical reaction for IL-6 in brown, used as the 
mask. (B) Image Pro Plus™ analysis of the positive immunohistochemical reaction identified by the software 
through a sample of brown coloration considered appropriate by the observer; pattern followed for all fields 
analyzed. The mean of all positive reactions represent the immunohistochemical expression of IL-6 (measured in 
μm2). Scale bar: 100 μm (magnification ×10). 
2.4. Statistical analysis 
To compare the groups regarding the area, analysis of variance with a nonparametric Kruskal–Wallis 
test was used. To compare the control and affected groups, the non-parametric Mann–Whitney test 
was used. To meet the symmetric condition of the variable, data for the area were previously 
submitted to a logarithmic transformation. A p value < 0.05 was considered statistically significant for 
the nonparametric Kruskal–Wallis test, and a p value < 0.025 for the non-parametric Mann–Whitney 
test. Data were analyzed with the software IBM SPSS Statistics v.20 (IBM Corporation, Armonk, NY, 
USA). 
3. Results 
Expression of IL-6 was observed at cytoplasmatic membrane, especially in fibrochondrocytes (Fig. 2, 
Fig. 3). However, statistically significant differences were not found between TMJ samples of acute 
pathology, ADDwR and ADDwoR. No association was found between the groups ADDwR and acute 
pathology, and between the groups ADDwoR and acute pathology. Also, statistically significant 
differences were not found between the TMJ discs of patients with and without osteoarthrosis. 
 
Fig. 2. Immunostaining for IL-6 in the temporomandibular joint disc of patients affected by disc displacement 
with reduction (ADDwR). (A) Magnification of ×10. Arrow indicates fibrochondrocyte. (B) Magnification of ×20. 
Arrow indicates fibrochondrocyte. Scale bar: 100 μm. 
 
Fig. 3. Immunostaining for IL-6 in the temporomandibular joint disc of patients affected by disc displacement 
without reduction (ADDwoR). (A) Magnification of ×10. Arrow indicates fibrochondrocyte. (B) Magnification of 
×20. Arrow indicates fibrochondrocyte. Scale bar: 100 μm. 
3.1. Expression of IL-6 in TMJ sample acute pathology x ADDwR x ADDwoR 
Significant differences were not found in the expression of IL-6 in TMJ discs among the three groups for 
the variable area (p = 0.303) (Table 2). 
 
Table 2. IL-6 area of immunostaining (μm2) in the discs of the control (acute pathology) and study 
group with and without disc reduction. 
Variable Group n Mean Median Minimum Maximum Standard deviation p-value* 
Area 
Control 4 61.8 53.8 42.4 97.1 25.6  
With reduction 17 55.5 44.7 12.8 248.3 52.8  
Without reduction 17 77.1 51.6 28.8 225.1 58.7 0.303 
* Nonparametric Kruskal–Wallis test, p < 0.05. 
 
3.2. Expression of IL-6 in TMJ sample acute pathology x ADDwR 
Significant differences were not found in the expression of IL-6 in TMJ discs between the groups acute 
pathology and ADDwR for the variable area (p = 0.361) (Table 3). 
 
Table 3. IL-6 area of immunostaining (μm2) in the discs of the control (acute pathology) and group with 
disc reduction. 
Variable Group n Mean Median Minimum Maximum Standard deviation p-value* 
Area 
Control 4 61.8 53.8 42.4 97.1 25.6  
With reduction 17 555 44.7 12.8 248.3 52.8 0.361 
* Nonparametric Mann–Whitney test, p < 0.025. 
 
3.3. Expression of IL-6 in TMJ sample acute pathology x ADDwoR 
Significant differences were not found in the expression of IL-6 in TMJ discs between the groups acute 
pathology and ADDwoR for the variable area (p = 0.965) (Table 4). 
 
Table 4. IL-6 area of immunostaining (μm2) in the discs of the control (acute pathology) and study 
group without disc reduction. 
Variable Group n Mean Median Minimum Maximum Standard deviation p-value* 
Area 
Control 4 61.8 53.8 42.4 97.1 25.6  
Without reduction 17 77.1 51.6 28.8 225.1 58.7 0.965 
* Non parametric Mann–Whitney test, p < 0.025. 
 
3.4. Expression of IL-6 in TMJ discs of patients with and without osteoarthrosis 
It was observed that all the patients with ADDwoR presented with OA. 
Statistically significant differences were not found in the expression of IL-6 in TMJ discs between the 
groups with and without OA for the variable area (p = 0.248) (Table 5). 
 
Table 5. Differences between groups with and without osteoarthrosis with respect to area of in situ 
expression (μm2) of cytokine IL-6. 
Variable Group n Mean Median Minimum Maximum Standard deviation p-value* 
IL-6 area 
Without osteoarthrosis 21 56.7 44.7 12.8 248.3 48.3  
With osteoarthrosis 17 77.1 51.6 28.8 225.1 58.7 0.248 
* Student t-test for independent samples, p < 0.05. 
4. Discussion 
For the past few years, many papers have been published showing the participation of various markers 
and distinct pathways in the progression of TMJ ID using TMJ discs and synovial fluid (Kubota et al., 
1998, De Alcantara Camejo et al., 2014, Loreto et al., 2013, Wake et al., 2013, Kim et al., 2012, Leonardi 
et al., 2011, Loreto et al., 2011, Leonardi et al., 2010a, Leonardi et al., 2010, Loreto et al., 2010, Vernal 
et al., 2008, Sato et al., 2003). 
Sato et al., in 2003, performed a study using also an immuno-histochemical technique for the 
examination of synovial tissue from 46 temporomandibular joints with internal derangement in 44 
patients. As controls, they examined synovial tissue specimens from 7 joints with habitual dislocation 
without pain. In synovial tissues from 21 of the 46 joints with internal derangement, IL-6 was expressed 
in the synovial lining cells and in the mononuclear cells infiltrating the periphery of the blood vessels. 
The density of IL-6-stained cells in specimens with ID correlated significantly with the grade of joint 
effusion shown by magnetic resonance imaging (p = 0.01, r = 0.32). 
In diseases of the TMJ, the synovium and articular cartilage produced various mediators that have the 
potential to induce chondrocyte death through necrosis or apoptosis (Houston and O’connell, 2004, Gu 
et al., 2002). De Alcantara Camejo et al., (2014) showed a higher expression of FasL, an apoptotic 
marker, in TMJ discs with reduction when compared with discs without reduction (in which a less 
intense inflammatory process and more mechanical stress may coexist), and a lower expression of this 
marker in the discs of patients with osteoarthrosis. This suggests that apoptosis may protect against 
TMJ disorder progression, and reinforces that necrosis should be the main means of cell death in OA 
fibrochondrocytes. 
One of the most important and studied pathways in the progression of TMJ ID is inflammation. The 
clinical symptoms of temporomandibular disorders involve pain and dysfunction during mandibular 
movement, which are basically symptoms of inflammation. Inflammatory changes in the TMJ modify 
physical and functional properties, first reversibly and finally irreversibly, reducing its ability to 
withstand pressure and compression forces (Israel et al., 1991). Loreto et al. (2013). showed that 
MMP-7 and MMP-9 are expressed in arthritic joints, and provided evidence of a role for those MMPs in 
disc damage in TMJ ID, with higher expression detected in the posterior band rather than in the 
anterior and intermediate bands of ADDwR and ADDwoR discs. Cytokines have emerged as the master 
controllers of hard tissue degradation in human joint tissue in both osteoarthritis and inflammatory 
arthritis models (Nishimura et al., 2002, Fu et al., 1995). Kim et al. (2012), using TMJ synovial fluid, 
demonstrated a higher expression of IL-1β, IL-6 and granulocyte macrophage colony stimulating factor 
(GM-CSF) in patients with temporomandibular dysfunction. 
IL-6 is one of the main cytokines involved in this process. It is produced by many kinds of cells, such as 
monocytes/macrophages, T cells, fibroblasts, and endothelial cells, and promotes T-cell and B-cell 
differentiation, usually elevated in sepsis or aseptic inflammation (such as rheumatoid arthritis) (Lipsky, 
2006). 
IL-6 may have a role in both acute and chronic phases of inflammation. Acute inflammation is a 
beneficial and limited response, particularly during infectious conditions, whereas chronic 
inflammation is a persistent phenomenon that can lead to tissue damage and to angiogenesis involving 
the synovium, articular cartilage, and bone. One characteristic of acute inflammation is that initially, 
the infiltration of leukocytes is predominantly neutrophilic, but after 24–48 h, monocytic cells 
predominate. In contrast, chronic inflammation is associated histologically with the presence of 
mononuclear cells such as lymphocytes and macrophages. 
IL-6 causes not only the acute phase reaction, but also the development of specific cellular and 
immune humoral responses, including the final stage of B-cell differentiation, immunoglobulin 
secretion and activation of T cells. The main mechanism of acute inflammation to chronic inflammation 
is the recruitment of monocytes to the inflammation area, which explains the importance of IL-6 in this 
process. In models of chronic inflammatory diseases, such as arthritis induced by collagen, IL-6 is pro-
inflammatory, whereas in models of acute inflammation, IL-6 exhibits an anti-inflammatory profile 
(Kaplanski et al., 2003, Yamamoto et al., 2000, Alonzi et al., 1998). 
Since the inflammatory process influences the progression of ID, this study was designed to test the 
hypothesis that IL-6 may be more highly expressed in the TMJ disc in cases of ADDwR and ADDwoR, 
and not only in the synovial fluid, as already extensively described in the literature (De Alcantara 
Camejo et al., 2014, Loreto et al., 2013, Kim et al., 2012, Sato et al., 2003). 
Although Brazil has a mixed population, our study population was formed only by individuals of 
Caucasian/white ethnicity, which can be explained because this study was carried out in the southern 
region of Brazil, where the majority of the population is descended from Europeans, especially from 
Poles, Ukrainians, Germans and Italians. Discopexy with disc repositioning was performed using a 
Mitek anchor in all patients in the acute pathology group and in most cases of ADDwR. In 2 cases (2 
samples from 2 different patients), the TMJ disc was highly compromised and discectomy was 
performed. Due to the degenerative impairment found in all cases of ADDwoR, discectomy was 
performed and physiotherapy instituted. 
Significant differences were not observed between the groups by acute pathology and with and 
without anterior disc reduction of the articular disc with respect to the variable area for the expression 
of IL-6 as measured by immunohistochemical examination. It was observed, however, that although an 
increase was not statistically significant, a higher IL-6 expression was found in the group with the more 
extreme phenotype (without reduction), in which continuous chronic inflammation had jeopardized 
the tissue. 
The presence of TMJ OA was also investigated to better understand the relationship between TMJ disc 
displacement and IL-6 expression. OA is a focal degenerative disorder that primarily affects the 
articular cartilage and subchondral bone of synovial joints such as TMJ, which ultimately relies on 
osteoclastic activity (Vernal et al., 2008, Dimitroulis, 2005). There is consensus that TMJ disc 
displacement and OA often occur concomitantly, and that disc displacement may promote OA 
(Dimitroulis, 2005, Nagai et al., 2003, De Bont et al., 1997). In our study no significant differences were 
observed between the groups with and without osteoarthrosis with respect to the variable area for the 
expression of IL-6 as measured by immunohistochemical examination, but the results suggested a 
higher expression in the group with osteoarthritis, the last stage of a chronic inflammatory destructive 
process. This may represent a frustrated attempt to control disease progression. 
The lack of difference between the groups in this study does not mean, however, that the levels of IL-6 
are not really increased in cases of disc displacement without reduction, and with osteoarthrosis. 
This study has some limitations, such as the small sample size together with the control group, which 
includes patients with condyle fracture (acute pathology). Although the sample size is extremely 
reduced, it is noteworthy that only about 5% of people worldwide present with a functional or 
pathological TMJ problem that is amenable to surgery (Dimitroulis, 2011, Dimitroulis, 2011a) and, for 
ethical reasons, it is not possible to retrieve healthy retrodiscal tissue from normal patients to serve as 
controls. In our results, an inﬂammatory cellular inﬁltrate was seldom observed in this group with 
acute pathology used as controls (patients with mandibular condyle fractures) associated with the 
degree of vascularization. Although showing normal characteristics and without a previous history of 
pain and/or functional limitation, this findings perhaps was due to the fact that the disc is a continually 
remodeling anatomic structure in a progressive process of healing in response to micro or macro 
trauma during functional biomechanical movements. Moreover, our sample may be one of largest 
samples in vivo composed of articular discs. Besides, there was a very high variability in IL-6 expression 
inside each group, caused, for example by age, individual response, and time of disease progression, 
which might have contributed to this finding. 
5. Conclusion 
The statistically significant differences observed in the analysis of this study, suggest the importance of 
IL-6 expression in temporomandibular articular discs on the progression of TMJ ID. A higher IL-6 
expression was found in the group with a more extreme phenotype (without reduction), in which 
continuous chronic inflammation has jeopardized the tissue; and a higher expression in the group with 
osteoarthritis (the last stage of a chronic inflammatory destructive process), which may represent a 
frustrated attempt to control disease progression. 
Future studies should be conducted with a larger in vivo sample size, with a varied ethnic group, and 
with other inflammatory markers, which could clarify the impact of inflammation on the progression of 
TMJ ID. 
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